期刊文献+

Gilbert综合征1例

下载PDF
导出
摘要 现肝脏囊肿半月余”于2017年12月5日入院。该患者缘于出生后即出现皮肤巩膜黄染,无皮肤瘙痒,生长发育正常,日常生活如常。皮肤巩膜黄染可因劳累或感冒后加重,经休息后可缓解,无明显不适症状,未行诊治;半月前体检发现肝内多发囊肿,今为求进一步诊治就诊于我院,门诊以“肝囊肿,黄疸原因待查”收入我科,病程中无腹胀,无恶心、呕吐,无寒战、发热,无咳嗽、咳痰,无胸痛,无返酸嗳气,无呕血,无心悸气短,偶有乏力,体重无减轻。饮食、睡眠良好,排尿、排便如常。患者既往体健,否认肝炎病史,否认外伤、手术及输血史。其父母无皮肤及巩膜黄染史,其姐姐为Gilbert综合征患者。
出处 《肝脏》 2018年第9期848-850,共3页 Chinese Hepatology
  • 相关文献

参考文献2

二级参考文献22

  • 1沈健,吴建新,李定国.1例中国Gilbert综合征家系UGT1A1基因遗传分析[J].胃肠病学,2007,12(7):392-396. 被引量:17
  • 2ClaridgeLC,Armstrong MJ, Booth C, et al. Gilbert’s syndrome.BMJ, 2011, 342: d2293.
  • 3Owens IS,Ritter JK. Gene structure at the human UGTl locuscreates diversity in isozyme structure, substrate specificity, andregulation. Prog Nucleic Acid Res Mol Biol, 1995,51:305-338.
  • 4Schwertner HA, Vitek L. Gilbert syndrome, UGTl Al * 28allele, and cardiovascular disease risk: possible protectiveeffects and therapeutic applications of bilirubin.Atherosclerosis, 2008,198 : 1-11.
  • 5McLeod HL,Parodi L, Sargent DJ, et al. UGTl Al * 28,toxicity and outcome in advanced colorectal cancer: results fromtrial N9741. J clin oncol, 2006,24: S151.
  • 6Liu CY, Chen PM,Chiou TJ,et al. UGTl Al * 28 polymor-phism predicts irinotecan-induced severe toxicities withoutaffecting treatment outcome and survival in patients withmetastatic colorectal carcinoma. Cancer, 2008, 112:1932-1940.
  • 7Lankisch TO, Schulz C,Zwingers T,et al. Gilbert? ssyndrome and irinotecan toxicity: combination with UDP-glucuronosyltransferase 1A7 variants increases risk. CancerEpidemiol Biomarkers Prev, 2008,17: 695-701.
  • 8Girard H,Villeneuve L,Court MH, et al. The novel UGT1A9intronic 1399 polymorphism appears as a predictor of 7-ethyl-10-hydroxycamptothecin glucuronidation levels in the liver. DrugMetab Dispos, 2006,34: 1220-1228.
  • 9Rotger M,Taffe P, Bleiber G,et al. Gilbert syndrome and thedevelopment of antiretroviral therapy-associated hyperbilirubi-nemia. J Infect Dis, 2005 , 192 : 1381-1386.
  • 10Lankisch TO, Behrens G, Ehmer U, et al. Gilbert’s syndromeand hyperbilirubinemia in protease inhibitor therapy: anextended haplotype of genetic variants increases risk in indinavirtreatment. J Hepatol, 2009,50: 1010-1018.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部